[DOI] [PubMed] [Google Scholar] 80.Anisimov V.N., Khavinson V.K., Popovich I.G., Zabezhinski M.A
The Food and Drug Administration declared the shortage over in 2025, yet telehealth companies still sell compounded versions of the anti-obesity drugs, tailoring the medications to different dosages and often selling them for less than what pharmaceutical companies charge for the brand-name drugs
The Median Time for Discharged ED Patients measure (75 FR 72086) and the Left Without Being Seen measure (75 FR 72088 through 72089) were adopted in the CY 2011 OPPS/ASC final rule with comment period to promote transparency, improve patient care and access to EDs, and reduce avoidable delays in the emergency care setting
When you are working with a potent GLP-1 receptor agonist like tirzepatide, those percentage differences in accuracy matter for consistent results
For more visual learners, our friends over at MorelliFit have some excellent content that breaks down complex fitness and research topics